TMEM199 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.288400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.931000E-01
Normal-vs-Stage2
1.917760E-01
Normal-vs-Stage3
4.461800E-02
Normal-vs-Stage4
1.633170E-01
Stage1-vs-Stage2
3.386200E-01
Stage1-vs-Stage3
1.046210E-01
Stage1-vs-Stage4
4.474800E-01
Stage2-vs-Stage3
3.864400E-02
Stage2-vs-Stage4
9.685000E-01
Stage3-vs-Stage4
1.356240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.600400E-01
Normal-vs-AfricanAmerican
3.690000E-01
Normal-vs-Asian
1.599620E-01
Caucasian-vs-AfricanAmerican
8.294200E-01
Caucasian-vs-Asian
4.371000E-01
AfricanAmerican-vs-Asian
3.530400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.932400E-01
Normal-vs-Female
5.872600E-01
Male-vs-Female
2.306200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.450200E-01
Normal-vs-Age(41-60Yrs)
5.566800E-01
Normal-vs-Age(61-80Yrs)
3.789400E-01
Normal-vs-Age(81-100Yrs)
8.002200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.210200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.543440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.481600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.113900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.283800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.679000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.643700E-02
Normal-vs-Daily Drinker
2.727200E-01
Normal-vs-Weekly Drinker
1.127440E-01
Normal-vs-Occasional Drinker
9.982200E-01
Normal-vs-Social Drinker
7.767800E-01
Non Drinker-vs-Daily Drinker
1.575630E-01
Non Drinker-vs-Weekly Drinker
3.249600E-01
Non Drinker-vs-Occasional Drinker
3.504100E-02
Non Drinker-vs-Social Drinker
1.559630E-03
Daily Drinker-vs-Weekly Drinker
7.326800E-01
Daily Drinker-vs-Occasional Drinker
1.746550E-01
Daily Drinker-vs-Social Drinker
1.242640E-01
Weekly Drinker-vs-Occasional Drinker
1.150370E-01
Weekly Drinker-vs-Social Drinker
5.858400E-02
Occasional Drinker-vs-Social Drinker
7.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.989150E-01
Normal-vs-Grade 2
5.322800E-01
Normal-vs-Grade 3
5.108200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.324190E-01
Grade 1-vs-Grade 3
2.137600E-01
Grade 1-vs-Grade 4
1.989150E-01
Grade 2-vs-Grade 3
5.066200E-01
Grade 2-vs-Grade 4
5.322800E-01
Grade 3-vs-Grade 4
5.108200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.214380E-01
Normal-vs-NonDiabetic
5.626600E-01
Diabetic-vs-NonDiabetic
3.311900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.553200E-01
Normal-vs-NoPancreatitis
4.310000E-01
Pancreatitis-vs-NoPancreatitis
9.576400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.832800E-01
Normal-vs-N1
2.193000E-01
N0-vs-N1
2.268400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.128000E-01
Normal-vs-TP53-NonMutant
7.234000E-01
TP53-Mutant-vs-TP53-NonMutant
9.336200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
